For the Inventor, By the Inventor

Enter assignee name

H. Lundbeck A/s

USPTO Granted Patents = 506

CIPO Patents = 174

EPO Patents = 160

Trademarks = 105

Forward Citations = 1,857

Loading Chart...

Loading Chart...

690 inventors (with patents filed for the assignee):

Jan Kehler (64 out of 65 patents)

Karsten Juhl (51 out of 53 patents)

Morten Langgård (46 out of 47 patents)

4. Jens Kristian Perregaard (43 out of 48 patents)

5. Benny Bang-Andersen (42 out of 44 patents)

6. Mauro Marigo (39 out of 39 patents)

7. Lars Kyhn Rasmussen (39 out of 43 patents)

8. Hans Petersen (34 out of 34 patents)

9. Mikkel Jessing (31 out of 33 patents)

10. Heidi Lopez De Diego (29 out of 33 patents)

11. Ejner Knud Moltzen (28 out of 30 patents)

12. Kim Andersen (26 out of 27 patents)

13. John A Latham (25 out of 122 patents)

14. Klaus Gjervig Jensen (24 out of 26 patents)

15. John Paul Kilburn (24 out of 29 patents)

Core Competencies:

Anti-ACTH Antibodies

Catecholamine Prodrugs

MAGL Inhibitors

Synucleinopathy Treatment

Anti-CGRP Antibodies

LRRK2 Inhibitors

Deuterated Indanes

Alcohol Derivatives

Crystalline Forms

Combination Treatments

Photophobia Conditions

Glucose Metabolism Regulation

506 patents: Sort by Forward Citations

1. 12479801 - Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4',5′:5,6]benzo[1,2-g]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol (2025-11-25),

2. 12428475 - Humanized anti-ACTH antibodies and use thereof (2025-09-30),

3. 12421303 - Agents, uses and methods for the treatment of synucleinopathy (2025-09-23),

4. 12421271 - Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2025-09-23),

5. 12398169 - Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid (2025-08-26),

6. 12398106 - Catecholamine carbamate prodrugs for use in the treatment of parkinson's disease (2025-08-26),

7. 12391749 - Acute treatment and rapid treatment of headache using anti-CGRP antibodies (2025-08-19),

8. 12391650 - Catecholamine prodrugs for use in the treatment of Parkinson's disease (2025-08-19),

9. 12384837 - Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP antibodies (2025-08-12),

10. 12384836 - Treatment of headache using anti-CGRP antibodies (2025-08-12),

11. 12384765 - Catecholamine prodrugs for use in the treatment of Parkinson's Disease (2025-08-12),

12. 12378219 - Crystalline forms of a MAGL inhibitor (2025-08-05),

13. 12358975 - Compositions and methods for treating synucleinopathies (2025-07-15),

14. 12358974 - Compositions and methods for treating synucleinopathies (2025-07-15),

15. 12351627 - Anti-ACTH antibodies and use thereof (2025-07-08),

H. Lundbeck A/S is a Danish pharmaceutical company specializing in the research, development, production, and marketing of pharmaceutical drugs for the treatment of psychiatric and neurological disorders. Their mission is to improve the lives of people struggling with brain diseases by providing innovative therapies. With a rich history spanning over a century, Lundbeck is dedicated to discovering breakthrough treatments and enhancing the quality of life for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

506 Patents

#1 in Valby

#9 in Denmark

#1,864 in the World

H. Lundbeck A/s

Forward Citations = 1,857

690 inventors:

Jan Kehler (64 out of 65 patents)

Karsten Juhl (51 out of 53 patents)

Morten Langgård (46 out of 47 patents)

4. Jens Kristian Perregaard (43 out of 48 patents)

5. Benny Bang-Andersen (42 out of 44 patents)

Please report any incorrect information to support@idiyas.com

Loading…